Catalyst Pharmaceuticals Acquired by Angelini Pharma | Healthcare M&A Deal

Angelini Pharma has acquired Catalyst Pharmaceuticals, a pharmacy business in Florida, for $X. Catalyst Pharmaceuticals develops and commercializes specialty pharmaceutical products, supporting pharmacy-focused patient access and treatment options. Angelini Pharma acquisitions in healthcare M&A target specialty drug capabilities and distribution reach to strengthen its strategic acquisition footprint in FL acquisitions. The merger acquisition is an announced strategic acquisition, structured as a merger acquisition between Angelini Pharma S.p.A. and a Delaware merger subsidiary, with deal terms and size undisclosed.